TriangleHEALTH PROFESSIONAL · SOURCE READING
Treatment options for hepatocellular carcinoma with metastases at diagnosis
Source: Childhood Liver Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: January 6, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.
Context: Hepatocellular Carcinoma / Treatment of Hepatocellular Carcinoma
No specific treatment has proven effective for metastatic hepatocellular carcinoma in children and adolescents.
In two prospective trials, cisplatin plus either vincristine/fluorouracil or continuous-infusion doxorubicin was ineffective in adequately treating 25 patients with metastatic hepatocellular carcinoma.[21,23] Occasional patients may transiently benefit from treatment with cisplatin/doxorubicin therapy, especially if the localized hepatic tumor shrinks adequately enough to allow resection of disease and the metastatic disease disappears or becomes resectable.
Publication references
Read the original reference and check its publication notices.
Preserved source evidence · Not medical advice